---
title: "SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of MacroGenics, Inc. Securities and Sets a Lead Plaintiff Deadline of September 24, 2024"
description: "A class action lawsuit has been filed against MacroGenics, Inc. for making misleading statements about the safety data of its drug. The stock declined 77.4% after it was revealed that the drug was mor"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/209981727.md"
published_at: "2024-07-27T00:40:37.000Z"
---

# SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of MacroGenics, Inc. Securities and Sets a Lead Plaintiff Deadline of September 24, 2024

> A class action lawsuit has been filed against MacroGenics, Inc. for making misleading statements about the safety data of its drug. The stock declined 77.4% after it was revealed that the drug was more dangerous than previously represented. Investors have until September 24, 2024 to request to be appointed as lead plaintiff.

NEW YORK, July 26, 2024 ( GLOBE NEWSWIRE ) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of MacroGenics, Inc. ( "MacroGenics" or the "Company" ) MGNX between March 7, 2024 to May 9, 2024, both ...

### Related Stocks

- [DRUG.AU - BetaShares Holdings Pty Ltd.](https://longbridge.com/en/quote/DRUG.AU.md)
- [MGNX.US - Macrogenics](https://longbridge.com/en/quote/MGNX.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Trump Launches Health Care Plan to Reduce Drug Costs | President Trump has launched "The Great Healthcare Plan" aimed at reducing prescription drug prices and insurance premiu | [Link](https://longbridge.com/en/news/272738903.md) |
| 13:31 ET
			
			
				The Journal of Clinical Pharmacology Celebrates 65 Years of Advancing Clinical Pharmacology | The Journal of Clinical Pharmacology (JCP) celebrates its 65th anniversary, highlighting its role in advancing clinical  | [Link](https://longbridge.com/en/news/272592270.md) |
| FDA prevails over EMA in 2025 novel drug approvals | In 2025, the FDA approved 46 new drugs, surpassing the EMA's 38 approvals. However, both agencies saw a decline in appro | [Link](https://longbridge.com/en/news/272953055.md) |
| FOCUS-Some drugmakers quietly concerned about legal risk with speedy FDA review program | Major drugmakers are participating in the FDA's expedited review program, but some are hesitant due to potential legal r | [Link](https://longbridge.com/en/news/272824482.md) |
| EXPLAINER-Hazards of ketamine in focus after actor Matthew Perry's 2023 overdose death | Actor Matthew Perry's 2023 death from a ketamine overdose has highlighted the drug's hazards. Originally used as an anes | [Link](https://longbridge.com/en/news/268406897.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.